Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

Market Cap	6.17B
Revenue (ttm)	1.06B
Net Income (ttm)	295.09M
Shares Out	428.49M
EPS (ttm)	0.69
PE Ratio	20.93
Forward PE	18.59
Dividend	0.28 (1.96%)
Ex-Dividend Date	May 23, 2025

Volume	2,113,764
Average Volume	4,914,713
Open	14.35
Previous Close	14.41
Day's Range	14.26 - 14.43
52-Week Range	12.45 - 18.05
Beta	0.32
RSI	56.02
Earnings Date	Oct 27, 2025

About SHA:688389

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well as offer...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688389

Financial Performance

In 2024, SHA:688389's revenue was 1.15 billion, an increase of 0.20% compared to the previous year's 1.15 billion. Earnings were 345.39 million, an increase of 5.12%.